Ceftriaxone Dosing and Treatment Duration for Bacterial Infections
For most adult bacterial infections, administer ceftriaxone 1-2 grams IV/IM once daily for 4-14 days, with specific dosing determined by infection site and severity: use 2 grams every 12 hours (total 4 grams daily) for meningitis, 2 grams once daily for endocarditis (4-6 weeks), and 1 gram once daily for disseminated gonococcal infection. 1, 2
Adult Dosing by Infection Type
Central Nervous System Infections
- Bacterial meningitis requires 2 grams IV every 12 hours (total 4 grams daily), continued for pathogen-specific durations 1, 2
- Pneumococcal meningitis: 10-14 days of treatment, extending duration if clinical response is delayed 1
- Meningococcal meningitis: 5 days of treatment 1
- Gonococcal meningitis: 10-14 days at 1-2 grams IV every 12 hours 1
- Add vancomycin 15-20 mg/kg IV twice daily for penicillin-resistant pneumococci 1
- Add amoxicillin 2 grams IV every 4 hours for patients ≥60 years to cover Listeria monocytogenes 1
Endocarditis
- HACEK organisms: 2 grams IV/IM once daily for 4 weeks (native valve) or 6 weeks (prosthetic valve) 3, 1
- Highly penicillin-susceptible viridans streptococci (MIC ≤0.12 μg/mL): 2 grams IV/IM once daily for 4 weeks as monotherapy 1
- Alternative short-course regimen: 2 grams IV/IM once daily for 2 weeks plus gentamicin 3 mg/kg daily, but avoid in patients with cardiac/extracardiac abscess, creatinine clearance <20 mL/min, or eighth cranial nerve dysfunction 1
- Gonococcal endocarditis: 1-2 grams IV every 12 hours for at least 4 weeks 1
Gonococcal Infections
- Uncomplicated infections: 250 mg IM as single dose 1, 2
- Disseminated gonococcal infection (DGI): 1 gram IM/IV every 24 hours, continue for 24-48 hours after improvement begins, then switch to oral therapy to complete 7 days total 1
- Gonococcal conjunctivitis: 1 gram IM single dose with saline lavage of infected eye 1
Other Serious Infections
- Standard dosing for most infections: 1-2 grams once daily or divided twice daily depending on severity 2
- Pyelonephritis: Initial 1 gram dose, then transition to oral therapy 1
- Lyme disease: 2 grams IV once daily for 2-4 weeks 1
- Neurosyphilis (penicillin-allergic patients): 2 grams daily IM or IV for 10-14 days 1
Surgical Prophylaxis
- Single dose of 1 gram IV administered 30 minutes to 2 hours before surgery 2
Pediatric Dosing
Neonates (≤28 days)
- Contraindicated in hyperbilirubinemic neonates and premature infants 4, 2
- Contraindicated if calcium-containing IV solutions are required 2
- Postnatal age ≤7 days: 50 mg/kg/day every 24 hours 4
- Postnatal age >7 days and ≤2000 g: 50 mg/kg/day every 24 hours 4
- Postnatal age >7 days and >2000 g: 50-75 mg/kg/day every 24 hours 4
- Administer IV doses over 60 minutes to reduce bilirubin encephalopathy risk 2
- Gonococcal infections: 25-50 mg/kg/day IV or IM single dose for 7 days (10-14 days if meningitis documented) 1
Infants and Children
- Meningitis: 100 mg/kg/day (maximum 4 grams daily) divided every 12 hours or once daily 4, 2
- Serious infections (non-meningitis): 50-75 mg/kg/day divided every 12 hours (maximum 2 grams daily) 2
- Skin and soft tissue infections: 50-75 mg/kg once daily (maximum 2 grams daily) 2
- Acute otitis media: 50 mg/kg IM single dose (maximum 1 gram) 2
- Community-acquired pneumonia: 50-100 mg/kg/day once daily or divided every 12-24 hours 4
- Endocarditis: 100 mg/kg/day divided every 12 hours or 80 mg/kg/day once daily (maximum 4 grams daily) for 4-6 weeks 1
- Children ≥45 kg: use adult dosing regimens 1
- Children <45 kg with uncomplicated gonococcal infections: 125 mg IM single dose 1
- Children <45 kg with bacteremia/arthritis: 50 mg/kg daily for 7 days (10-14 days for meningitis) 1
Special Populations and Considerations
Renal and Hepatic Impairment
- No dosage adjustment necessary for renal or hepatic impairment alone 2
- Maximum adult dose should not exceed 4 grams daily 2
- Chronic renal failure on hemodialysis: 1 gram every other day has been used 5
Elderly Patients
- No modification required up to 2 grams per day if no severe renal/hepatic impairment 2
Outpatient Parenteral Antibiotic Therapy (OPAT)
- For stable, afebrile patients after 5 days inpatient therapy: 2 grams twice daily IV initially, with option to use 4 grams once daily IV after first 24 hours 1
- Requires reliable IV access and 24-hour access to medical advice 1
Administration Guidelines
Intravenous Administration
- Infuse over 30 minutes for adults and children; 60 minutes for neonates 2
- Recommended concentrations: 10-40 mg/mL 2
- Never use calcium-containing diluents (Ringer's, Hartmann's) due to precipitation risk 2
- In non-neonates, may administer sequentially with calcium-containing solutions if lines thoroughly flushed between infusions 2
Intramuscular Administration
- Reconstitute to 250 mg/mL or 350 mg/mL concentration 2
- Inject deep into large muscle mass with aspiration to avoid vascular injection 2
- IM injection is painful; counsel patients accordingly 1
Treatment Duration by Pathogen
- Streptococcus pyogenes: minimum 10 days 2
- Meningococcal meningitis: 5-7 days 1
- Pneumococcal meningitis: 10-14 days 1
- Listeria monocytogenes: 21 days 1
- Haemophilus influenzae meningitis: 10 days 1
- Enterobacteriaceae in CSF/blood: 21 days 1
- General guideline: continue therapy for at least 2 days after signs and symptoms resolve 2
- Usual duration for most infections: 4-14 days; complicated infections may require longer 2
Critical Pitfalls to Avoid
- Never administer ceftriaxone with calcium-containing solutions in neonates via any route 2
- Avoid in hyperbilirubinemic neonates due to displacement of bilirubin from albumin binding sites 2
- Treatment failures reported with 250-500 mg doses for pharyngeal gonococcal infections with elevated MICs; higher doses critical for such cases 1
- For ceftriaxone-resistant strains, twice-daily dosing of 2 grams may be necessary 1
- Add antichlamydial coverage if Chlamydia trachomatis suspected, as ceftriaxone has no activity against this organism 2
Adverse Effects
Common adverse effects include rash, fever, diarrhea, neutropenia, liver function abnormalities, and gallbladder "sludging" 1. Once-daily dosing offers convenience advantages and potential cost savings through OPAT without compromising efficacy 1, 6, 7, 8.